Semantic Scholar uses AI to extract papers important to this topic.
- British Journal of Cancer
5,6-Dimethylxanthenone-4-acetic acid, synthesised in this laboratory, reduces tumour blood flow, both in mice and in patients on… (More)
5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a new anticancer drug synthesized in this laboratory and currently in clinical… (More)
5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a drug synthesized in this laboratory that halts tumor blood flow and induces tumor… (More)
A number of antitumor agents are known to cause selective reduction in tumor blood flow, leading in some cases to tumor necrosis… (More)
- Cancer Chemotherapy and Pharmacology
5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a low-molecular-weight biological response modifier scheduled for clinical… (More)